{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (Q2'26)",
      "prediction": "BEAT",
      "answer": "pred ~$1.74 vs. cons $1.66",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted Sales/Revenue (Q2'26)",
      "prediction": "BEAT",
      "answer": "pred ~$23.3B vs. cons $22.88B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Free Cash Flow (Q2'26)",
      "prediction": "BEAT",
      "answer": "pred ~$2.0B vs. cons ~$1.9B",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 Adjusted EPS guide",
      "prediction": "BETTER",
      "answer": "guide ~$6.80-$7.00 (mid $6.90) vs. cons ~$6.83 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 Adjusted Sales guide",
      "prediction": "BETTER",
      "answer": "guide ~$93.0B-$94.0B (mid $93.5B) vs. cons ~$93.3B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 Free Cash Flow guide",
      "prediction": "UNCHANGED",
      "answer": "guide ~$8.25B-$8.75B (mid $8.5B) vs. cons ~$8.6B (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -3.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -5.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Q1'26 offers a direct precedent: RTX beat EPS by 16% and raised guidance, yet the stock still fell (~196 to ~172, a multi-day decline) as a priced-for-perfection valuation triggered profit-taking rather than relief. Into this print RTX has rallied back near those pre-Q1 levels (~$195), reloading the same setup. Even with another beat-and-raise, out-period math (persistent GTF Advantage OE-margin drag of a couple hundred million dollars, unresolved IEEPA tariff refund timing, and Raytheon book-to-bill that's been below 1.0x despite backlog growth) gives the Street reason to trim 2027 estimates on the margin-quality/cash-conversion side even as headline 2026 numbers rise, extending an initial negative reaction over the following days rather than reversing it.",
  "day5_confidence": "MEDIUM"
}